Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research Read more about Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research Read more about Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business Read more about Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp to Announce First Quarter Financial Results on April 25, 2024 Read more about Labcorp to Announce First Quarter Financial Results on April 25, 2024
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials Read more about Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer Read more about Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
Labcorp Launches Weight Loss Management Testing Solutions Read more about Labcorp Launches Weight Loss Management Testing Solutions
Labcorp Announces 2023 Fourth Quarter and Full Year Results Read more about Labcorp Announces 2023 Fourth Quarter and Full Year Results
